Introduction The presence of per- and polyfluoroalkyl substances (PFAS) in consumer products has become a critical concern in public health […]
Trace-Level PFAS Testing with LC-MS/MS: A Case Study on Consumer Product Packaging Read More »
Introduction: Why You Need the Right CRO for Unknown Impurity Identification In the pharmaceutical lifecycle, encountering an unexpected impurity—especially during
Best CRO Services for Identification of an Unknown Impurity in Canada and the U.S. Read More »
Introduction: Why Identification of an Unknown Impurity is Critical in Phase 3 Drug Development In late-stage pharmaceutical development, identification of
Introduction: The Role of Peptide Characterization in GLP-1 Analog Therapeutics In the development and QC stages of GLP-1 receptor agonists,
Peptide Characterization Case Study: Identifying Sequence Impurities in a GLP-1 Analog Read More »
Introduction: Why Addressing Leachables Risk in a Biologic Vial System is Crucial In 2025, the biopharmaceutical industry continues to face
E&L Testing CRO Case Study: Mitigating Leachables Risk in a Biologic Vial System Read More »
Introduction: Why Proactive Nitrosamine Testing is Critical in 2025 In 2025, regulatory scrutiny around nitrosamine contamination in pharmaceutical products continues
Introduction: Choosing the Right E&L Testing CRO in 2025 As regulatory expectations evolve and the demand for high-precision analytical testing
What to Look for in an E&L Testing CRO: 7 Must-Have Capabilities for 2025 Read More »
Introduction: Why E&L Testing Cost Matters More Than Ever in 2026 In 2026, the E&L Testing Cost is a crucial
How Much Does Extractables and Leachables (E&L) Testing Cost in 2026? Read More »
When it comes to safeguarding pharmaceutical product quality, nitrosamine impurity testing has become a critical component of regulatory compliance. As
For scientists and product developers working in materials, pharma, and advanced polymers, understanding GPC analysis is critical. Gel Permeation Chromatography
